AstraZeneca immunotherapy drug cuts lung cancer deaths by almost a third

AstraZeneca's immunotherapy drug Imfinzi cut the risk of death in patients with mid-stage lung cancer by nearly a third in a closely watched clinical study, reinforcing the case for using the drug in earlier disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news